1008-14: PMDD, Pregnancy & Psychopharmacology
Speaker: Laura G. Leahy, DrNPc, APN, PMH-CNS/FNP – Advanced Practice Nurse, APNSolutions, LLC
Disclosures: Discussion of off-label uses will take place during this presentation. The speaker and the activity planners have no conflicts of interest to disclose.
Session Length: 90 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
1. Identify 3 hormones impacting PMS/PMDD symptoms.
2. Discuss 2 supplements or complementary treatments for PMDD.
3. Discuss 3 dosing options for treating PMDD.
4. Discuss 2 classes of psychotropic medications & their impact on pregnancy & lactation.
Key words: hormones, mood swings, PMDD, PMS, pregnancy, psychopharmacology women's health
Continuing Nursing Education
1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
APNA 12th Annual Clinical Psychopharmacology Institute | Reston, Virginia
Saturday, June 21, 2014
Release Date: July 21, 2014
The contact hours for this session expire: July 31, 2016